Mettler-Toledo International Inc. Announces Webcast of Presentation at the Jefferies Healthcare Conference
May 25, 2023 17:15 ET
|
Mettler-Toledo, LLC
Columbus, OH, May 25, 2023 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Jefferies Healthcare Conference on Thursday, June...
Assembly Biosciences to Present During the 2023 Jefferies Healthcare Conference
May 23, 2023 16:05 ET
|
Assembly Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral...
Hillman Announces Participation at Upcoming Investor Conferences During June 2023
May 23, 2023 07:30 ET
|
The Hillman Group
CINCINNATI, May 23, 2023 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, today announced...
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
May 11, 2023 16:05 ET
|
Cyclacel
- Key Catalysts ahead with multiple Value Generating Readouts -- Expects to Report Phase 1/2 Data Releases with Oral Fadraciclib -- Advancing single-agent Efficacy with Differentiated Oral Plogosertib...
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2023 Fourth Quarter and Year End Earnings Release and Conference Call Webcast
May 11, 2023 16:05 ET
|
Cavco Industries, Inc.
PHOENIX, May 11, 2023 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended April 1, 2023 on Thursday, May 18, 2023 after the...
Broadwind Announces First Quarter 2023 Results
May 11, 2023 07:00 ET
|
Broadwind
CICERO, Ill., May 11, 2023 (GLOBE NEWSWIRE) -- Broadwind, Inc. (Nasdaq: BWEN, “Broadwind” or the “Company”), a diversified precision manufacturer of specialized components and solutions serving...
Veru Reports Fiscal 2023 Second Quarter Financial Results
May 11, 2023 06:30 ET
|
Veru Inc.
Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS),...
Yield10 Bioscience Announces First Quarter 2023 Financial Results
May 10, 2023 16:02 ET
|
Yield10 Bioscience, Inc.
Executing commercial strategy for elite Camelina in the biofuels marketMet target for 2023 contracted spring Camelina acresPermitting complete, planting underway for spring seed scale-up and field...
MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results
May 09, 2023 16:01 ET
|
MacroGenics, Inc.
ZYNYZ™ is third product approved in U.S. that originated from MacroGenics' pipelineMultiple Phase 2 programs advancing in metastatic castration-resistant prostate cancer (mCRPC)Cash runway through...
Arbutus to Present at JMP Securities Life Sciences Conference
May 09, 2023 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...